Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Intravenous bisphosphonate therapy and bisphosphonate-related osteonecrosis of the jaws.

Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons - 1 May 2009

Dodson Thomas B

Abstract excerpt

The purposes of this report are to 1) summarize the epidemiologic evidence supporting an association between intravenous bisphosphonate (BP) exposure and BP-related osteonecrosis of the jaws (BRONJ), 2) identify measurable risk factors associated with BRONJ, and 3) assess the risk of BRONJ for patients receiving intravenous BPs to manage osteoporosis. The results of this review suggest a compelling,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Density Conservation Agents
Share to Bone Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diphosphonates

Share to Injections, Intravenous

Share to Multiple Myeloma

Share to Osteonecrosis

Share to Osteoporosis

Share to Sex Factors

Source

Identifiers

PMID: 19371814
DOI: 10.1016/j.joms.2008.12.004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Intravenous bisphosphonate therapy and bisphosphonate-related osteonecrosis of the jaws.PMID 19371814Read ↗

Ninety-one osteoporosis patients affected with bisphosphonate-related osteonecrosis of the jaw: a case series.Semantic proximity Read ↗

Is oral bisphosphonate-related osteonecrosis of the jaw an endemic condition?Semantic proximity Read ↗

Biphosphonates-associated osteonecrosis of the jaw: the role of gene-environment interaction.Semantic proximity Read ↗

Denosumab-Related Osteonecrosis of the Jaw: a five year monocentric retrospective study of Ancona General HospitalSemantic proximity Read ↗

New approach to analyze genetic and clinical data in bisphosphonate-induced osteonecrosis of the jaw.Semantic proximity Read ↗

Genetic polymorphisms and other risk factors associated with bisphosphonate induced osteonecrosis of the jaw.Semantic proximity Read ↗

Pharmacogenetics of Bisphosphonate-associated Osteonecrosis of the JawSemantic proximity Read ↗

Osteonecrosis of the Jaw and the Role of MacrophagesSemantic proximity Read ↗

Bisphosphonate-related osteonecrosis: genetic and acquired risk factors.Semantic proximity Read ↗

Can peripheral blood γδ T cells predict osteonecrosis of the jaw? An immunological perspective on the adverse drug effects of aminobisphosphonate therapy.Semantic proximity Read ↗

Pharmacogenetics of bisphosphonate-associated osteonecrosis of the jaw.Semantic proximity Read ↗

OSTEONECROSIS OF THE JAW (ONJ) IN BREAST CANCER PATIENTS: EFFECT OF PREVENTIVE MEASURES IN A MONOINSTITUTIONAL EXPERIENCESemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.